ONCOLOGY NURSE PRACTITIONERS AS PRINCIPAL INVESTIGATORS IN EARLY DRUG DEVELOPMENT CLINICAL TRIALS

被引：0

作者：

Jameson, Gayle ^{[1
]}

Pelusi, Jody ^{[2
]}

Rice, David ^{[3
]}

Sharrah, Karen ^{[4
]}

Burns, Kathleen ^{[4
]}

Von Hoff, Daniel ^{[1
,5
]}

机构：

[1] HonorHealth, Scottsdale, AZ USA

[2] HonorHlth Res Inst, Scottsdale, AZ USA

[3] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[4] City Hope Natl Med Ctr, Duarte, CA USA

[5] Translat Genom Inst, Phoenix, AZ USA

来源：

ONCOLOGY NURSING FORUM | 2019年 / 46卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

442

引用

页数：2

共 50 条

[41] DEVELOPMENT OF TREATMENT GUIDES AND A DRUG FORMULARY FOR NURSE-PRACTITIONERS [J].

WEST, S ;

JOHNSON, R .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1973, 30 (04) :316-320

[42] Evolution of early phase clinical trials in oncology [J].

Bui, Nam Q. ;

Kummar, Shivaani .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (01) :31-38

[43] Evolution of early phase clinical trials in oncology [J].

Nam Q. Bui ;

Shivaani Kummar .

Journal of Molecular Medicine, 2018, 96 :31-38

[44] Barriers and facilitators to giving prehabilitation advice by clinical nurse specialists and advanced nurse practitioners in oncology patients [J].

Tessa Renouf ;

Rachael Barlow ;

Tunia Patel .

Supportive Care in Cancer, 2024, 32

[45] Barriers and facilitators to giving prehabilitation advice by clinical nurse specialists and advanced nurse practitioners in oncology patients [J].

Renouf, Tessa ;

Barlow, Rachael ;

Patel, Tunia .

SUPPORTIVE CARE IN CANCER, 2024, 32 (03)

[46] Clinical implications of drug-induced liver injury in early-phase oncology clinical trials [J].

Mondaca, Sebastian P. ;

Liu, Dazhi ;

Flynn, Jessica R. ;

Badson, Sandy ;

Hamaway, Stefan ;

Gounder, Mrinal M. ;

Khalil, Danny N. ;

Drilon, Alexander E. ;

Li, Bob T. ;

Jhaveri, Komal L. ;

Schram, Alison M. ;

Kargus, Katherine E. ;

Kasler, Mary Kate ;

Blauvelt, Natalie M. ;

Segal, Neil H. ;

Capanu, Marinela ;

Callahan, Margaret K. ;

Hyman, David M. ;

Gambarin-Gelwan, Maya ;

Harding, James J. .

CANCER, 2020, 126 (22) :4967-4974

[47] Clinical Trials and Drug Development [J].

Mahipal, Amit .

CANCER CONTROL, 2014, 21 (03) :188-189

[48] Drug development: Clinical trials [J].

Jaffe, S .

SCIENTIST, 2003, 17 (10) :12-12

[49] Principal investigator gender and trial success in gynecologic oncology clinical trials [J].

Barry, Danika ;

Richardson, Michael ;

Steinberg, Jecca ;

Thirunavu, Vineeth ;

Strom, Danielle ;

Turner, Brandon ;

Weeks, Brannon ;

Laasiri, Nora ;

Squires, Natalie ;

Anderson, Jill ;

Young, Anna Marie ;

Andebrhan, Sarah ;

Perry, Madeline ;

Zhang, Naixin ;

Holder, Kai ;

Roque, Dario ;

Salani, Ritu .

GYNECOLOGIC ONCOLOGY, 2023, 176 :S281-S282

[50] Circulating tumor DNA: a biomarker for oncology drug development in phase I clinical trials? [J].

Asnaghi, Riccardo ;

Marsicano, Renato M. ;

Fuorivia, Valeria ;

Malvezzi, Giulia ;

Etessami, Julian D. ;

Izzo, Davide ;

Valenza, Carmine ;

Curigliano, Giuseppe ;

Trapani, Dario .

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2025,

← 1 2 3 4 5 →